WHO releases new guidelines and gives countries a green light to use long-acting injectable
The World Health Organization-WHO on Thursday released new guidelines giving countries a green light to use long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. The guidelines that were released ahead of the annual International AIDS Conference will support countries as they plan for CAB-LA introduction as part of a comprehensive approach to HIV…